MACKENZIE FINANCIAL CORP
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,774,380
+$9,552,948 QoQ
Shares Held
599,576
+968.2% QoQ
Ownership
0.568%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 323 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $499,025,453 across 60 Biotechnology names. SRPT ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in SRPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,774,380 | 599,576 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,221,432 | 56,132 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,249,063 | 58,042 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $954,789 | 49,548 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $494,737 | 28,932 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,287,951 | 20,181 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,828,426 | 23,262 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $4,058,925 | 32,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,679,238 | 61,261 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,715,580 | 36,425 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $984,453 | 10,209 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,487,070 | 20,517 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,761,638 | 32,847 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,620,983 | 40,782 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $5,828,119 | 44,977 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,548,278 | 41,146 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $281,324 | 3,753 | Shares | Sole | 2022-08-10 | |
| 2020-12-31 | $1,151,659 | 6,755 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,369,332 | 9,751 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,368,061 | 14,769 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||